在Klebsiella pneumoniae中新出现的挑战:抗菌素耐药性和新的方法

相关实验视频

Updated: May 26, 2025

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

Assar Ali Shah¹, Ameen S S Alwashmi², Adil Abalkhail³

¹Department of Animal and Poultry Production, Faculty of Veterinary and Animal Science, Veterinary and Animal Science, Gomal University, Dera Ismail Khan, Pakistan; Tropical Feed Resources Research and Development Center (TROFREC), Department of Animal Science, Faculty of Agriculture, Khon Kaen University, Khon Kaen, 40002, Thailand.

Microbial pathogenesis

|February 21, 2025

概括

由于抗菌素耐药性 (AMR) 的增加,Klebsiella pneumoniae感染是一个日益增长的全球威胁. 菌体治疗和向毒性因子等新策略对于对抗这些难以治疗的多药耐药性 (MDR) 感染至关重要.

科学领域:

微生物学微生物学
传染性疾病传染性疾病
抗微生物耐药性研究研究

背景情况:

由于抗菌素耐药性 (AMR) 的升级,Klebsiella pneumoniae对全球健康构成了重大挑战.
耐多药 (MDR) 和耐卡巴胺菌株的增加严重限制了有效的治疗选择.
这种细菌采用了耐药机制,如扩展光谱β-乳糖酶 (ESBL) 生产和排泄.

研究的目的:

审查Klebsiella pneumoniae抗微生物耐药性 (AMR) 所带来的挑战.
探索新的治疗策略,以对抗抗性菌株.
突出传统抗生素之外的替代方法.

主要方法:

关于Klebsiella pneumoniae中的抗菌素耐药性机制的文献综述.
对新兴治疗方式的分析.
检查毒性因子和生物膜抑制策略.

主要成果:

克莱布西拉肺炎通过ESBL生产和排泄等机制表现出显著的AMR.
包括菌体疗法,CRISPR-Cas系统和抗微生物在内的新型治疗方法显示出有前途.
针对毒性因素和生物膜形成提供了替代的控制策略.

结论:

打击Klebsiella pneumoniaeAMR需要探索创新的治疗途径.
菌体治疗,CRISPR-Cas和抗菌是一种有希望的替代方案.
抑制毒性和生物膜的形成为管理感染提供了一个新的前沿.

关键词:

抗微生物耐药性 (AMR) 是一种在Klebsiella肺炎中.抗多种药物 (MDR) 耐药性公共卫生公共卫生治疗策略治疗策略

更多相关视频

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

相关概念视频

Antibiotic Selection

Antibiotic Selection

Defense Against Bacterial Pathogens

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...